Latest Eden Innovations (ASX:EDE) News

Eden Innovations has transformed its balance sheet, cutting interest-bearing liabilities from $16.97 million to negligible levels after year-end. But revenue fell 19%, the Group remained deeply loss-making and its auditor flagged a material uncertainty over going concern.

Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.

Eden Innovations reported strong EdenCrete® trial results in India and North America, strategic hires for EdenShield® in defence markets, and completed a $4.05 million placement, ending the quarter debt-free with $5.2 million cash.

Takeovers, mine studies and record quarterly updates drove the week, with buyers chasing companies that put hard numbers around cash flow, reserves and contract wins. Losses were just as sharp where traders sold into reopenings or questioned whether fresh capital and non-binding deals would turn into profits.

Eden Innovations is broadening its EdenCrete®Pz7 footprint with Amrize by adding four new concrete plants in Texas, Minnesota, and Toronto, supported by initial US$32,000 orders.

Eden Innovations has secured robust validation from India’s Central Road Research Institute showing its EdenCrete®Pz7 carbon nanotube admixture boosts concrete strength, durability, and sustainability in key infrastructure mixes.

Big moves came from small and mid-cap names tied to drilling, project studies and fresh funding. Healthcare, mining and takeover stocks all had a busy week, but not every strong announcement held its gains.

Eden Innovations has posted promising trial outcomes for its EdenCrete®Pz7 concrete additive across multiple sectors in India, highlighting performance gains and cost reductions amid the country’s rapid infrastructure growth.

Capital raisings drove the week in ASX tech, with investors backing AI and data centre spending but punishing deep discounts. The biggest moves came from small-cap fundraisings, while AI infrastructure names drew the clearest buying support.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

Eden Innovations appoints former European Parliament member Antanas Guoga to lead EdenShield’s push into European defence and critical infrastructure markets amid surging regional security spending.

Small-cap tech buyers chased AI, defence and digital infrastructure this week, while a few names gave back gains after reopening jumps. The biggest moves came from contract wins, fresh capital and clear signs that products are getting closer to real sales.